SCHEMBL6372155

SCHEMBL6372155

COC(=O)c1ccc(C(=O)NNC(=O)c2ccc(N3CCC(C(OC)c4ccccc4)CC3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
MAPT P10636 3/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 3/20 0.43
KMT2A Q03164 4/20 0.43
OPRD1 P41143 1/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
MEN1 O00255 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 1/20 0.42
GAA P10253 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
POLB P06746 1/20 0.41
HDAC3 O15379 2/20 0.41
HDAC8 Q9BY41 2/20 0.41
MCHR1 Q99705 1/20 0.41
NPY2R P49146 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7082982 0.92 USP2 (0.49) MAPTNPC1RAB9AKMT2AMEN1
SCHEMBL6375313 0.87 KMT2A (0.45) MAPTNPC1RAB9AKMT2AMEN1
SCHEMBL6379753 0.85 NPY2R (0.52) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL7082872 0.85 USP2 (0.56) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL6379080 0.84 NOX1 (0.46) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL7130127 0.80 ALDH1A1 (0.57) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL6135055 0.76 ACACB (0.49) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL6374861 0.75 NOX1 (0.45) TSHRGAA
SCHEMBL7341735 0.74 ALDH1A1 (0.60) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL6132215 0.73 KDM4E (0.53) ALDH1A1NPC1RAB9AKMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050181988-A1 Echinocandin cyclic peptide derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050181988-A1 Echinocandin cyclic peptide derivatives NGLY1, ARG1, ERG28 ALDH1A1 4014/4885MAPT 4050/4885NPC1 705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.